Glenmark launches antiviral drug Favipiravir for COVID -19
Video description:
Drugs to treat COVID-19 is cheered by the market. Surajit Pal of Prabhudas Lilladher speaks on Pharma surge. The drugmaker launched an antiviral drug Favipiravir (brand name FabiFlu®) for the treatment of mild to moderate Covid-19 patients. 'I really don't think there will be any benefit out this because there would be another two or three guys will be coming into the picture and given the fact that Remdesivir is also in the competition. The government expenditure will be through hospitals and that will be more for Remdesivir and again that product will not be very costly and it will have pandemic approval and it will not be much. Favipiravir will be another option to treat mild to moderate COVID-19 a[tients, says Surajit Pal of Prabhudas Lilladher Listen in! Subscribe To ET Now For Latest Updates On Stocks, Business, Trading | ► https://goo.gl/SEjvK3 Subscribe Now To Our Network Channels :- Times Now : http://goo.gl/U9ibPb The NewsHour Debate : http://goo.gl/LfNgFF To Stay Updated Download the Times Now App :- Android Google Play : https://goo.gl/zJhWjC Apple App Store : https://goo.gl/d7QBQZ Social Media Links :- Twitter - http://goo.gl/hA0vDt Facebook - http://goo.gl/5Lr4mC G+ - http://goo.gl/hYxrmj Website - www.etnownews.com
via https://youtu.be/UZmSJ0GFT_U
We do not own the video this is just a player link and it could contain by other parties.
Watch youtube video here: the best video collection
No comments:
Post a Comment